Owners and management
CVR: 46238656
Not available
Andrew Laskary (33,33-49,99%), Enzo Roberto Porrello (25-33,32%)
1 more
CVR · view owners
Andrew Laskary
Board: Andrew Laskary (chair)
CVR · view management
Active
Founded 6 February 2026
CVR · view overview
2 employees
CVR · 2026
Name registered: Ibnova Therapeutics ApS
CVR · 06/02/2026
View the full event history
Ibnova Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Laskary. The board consists of Andrew Laskary (chair). The company is owned by Andrew Laskary, Enzo Roberto Porrello and James Edward Hudson. The company has 2 employees (2026).
Selskabets formål er at forske i, udvikle, fremstille og kommercialisere therapeutiske produkter og beslægtede løsninger inden for life sciences og sundhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Ibnova Therapeutics ApS is 46238656.
Ibnova Therapeutics ApS is owned by Andrew Laskary, Enzo Roberto Porrello and James Edward Hudson.
The management of Ibnova Therapeutics ApS consists of Andrew Laskary.
The board of Ibnova Therapeutics ApS consists of Andrew Laskary, with Andrew Laskary as chair.
Ibnova Therapeutics ApS had 2 employees in 2026 according to the Danish CVR register.
Ibnova Therapeutics ApS was founded on 6 February 2026.
Claim this page to add your logo and social links. Free to get started.
As of February 6, 2026, Andrew Laskary has joined the board of directors of Ibnova Therapeutics ApS.
As of February 6, 2026, Andrew Laskary is registered as director of Ibnova Therapeutics ApS.
As of February 6, 2026, is registered as an owner of Ibnova Therapeutics ApS with an ownership share of 33%.
As of February 6, 2026, is registered as an owner of Ibnova Therapeutics ApS with an ownership share of 25%.
As of February 6, 2026, is registered as an owner of Ibnova Therapeutics ApS with an ownership share of 25%.
Ibnova Therapeutics ApS was founded on February 6, 2026.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 46481585
CVR 36465972
CVR 45436497
CVR 46059220
CVR 46543912
